$SLGN

Silgan Holdings Q2 Earnings Top Estimates on Rise in Metal Containers

Silgan Holdings (SLGN) reported Q2 2026 adjusted EPS of 98 cents, above the Zacks consensus of 96 cents. Net revenue rose 6.8% to $1.64 billion. Gross margin fell to 17.9%. The company reaffirmed 2026 adjusted earnings guidance of $3.73-$3.93 per share and free cash flow of $450 million.

Original reporting
Published Aug 3, 2026, 3:13 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 4, 2026, 2:58 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Silgan Holdings Q2 Earnings Top Estimates on Rise in Metal Containers — source image
Decision brief

The 30-second read

$SLGNNeutralMed
01

Why it matters

Traders can update expectations for 2026 earnings trajectory using reaffirmed guidance, while monitoring whether margin compression and cash flow weakness persist in upcoming quarters.

02

Market read

A reported adjusted EPS and revenue beat alongside reaffirmed full-year guidance creates a tradable setup, but margin and cash flow deterioration add downside risk to the immediate narrative.

03

What to watch

Operating cash flow was heavily negative in the first six months and cash fell sharply versus year-end, which can matter more than the adjusted EPS beat for valuation.

Relevance 7/10Novelty 7/10Timing: post-earnings, guidance reaffirmed in the same release

Background

The article summarizes Silgan Holdings’ Q2 2026 results across segments (dispensing and specialty closures, metal containers, custom containers) and reiterates its 2026 outlook.

Company-level read

Ticker impact

$SLGNNeutralMedium confidence
Context

Silgan reported Q2 2026 adjusted EPS of 98 cents, beating consensus, while reaffirming 2026 adjusted earnings guidance of $3.73 to $3.93.

Expected impact

Near-term volatility likely, with upside bias from the EPS and revenue beat offset by margin compression and lower cash balances.

Evidence & confidence

The article provides a concrete earnings and revenue beat plus unchanged full-year guidance, while also detailing gross margin decline and a large operating cash outflow in the first half.

Market effects

Packaging peers may see read-across on metal container demand and raw-material pass-through effectiveness, though this is company-specific.

No explicit regional demand shock is described; foreign currency translation is cited as a factor.

Raw-material cost pass-through and volume/mix dynamics are broadly relevant to global packaging supply chains.

Counterpoint

The EPS beat may be more pass-through driven than demand-driven, and margin compression plus weaker cash balances could cap the stock reaction.

Key entities

  • Silgan Holdings Inc.

    US packaging manufacturer reporting Q2 2026 adjusted EPS and reaffirming 2026 guidance.

Related articles

$SLGNMed

Silgan Holdings Inc. Q2 2026 Earnings Call Summary

Strategic Performance Drivers Management attributed Q2 performance to strong execution in high-value segments like fine fragrance and wet pet food, which helped offset geopolitical and inflationary headwinds. Dispensing and Specialty Closures (DSC) faced a 15% volume decline in Brazil due to inflationary market conditions, though management views this as a temporary market dynamic rather than a loss of share.

$SLGNMed

Silgan Q2 Earnings Call Highlights

Fabry said the combination of Brazil volume weakness and less favorable mix reduced second-quarter results by about $5 million. Despite that impact, adjusted EBIT in the segment was comparable with the prior year as favorable price over cost offset the volume and mix pressure. Greenlee highlighted continued strong growth in fine-fragrance dispensing products, particularly in Europe.

$SLGNMed

Silgan Q2 profit slips despite higher sales

Silgan has posted a net income of $75.8m for the second quarter (Q2) of 2026, down from $89m in the same period of 2025. Quarterly sales reached $1.64bn, an increase of $104.1m, or 7%, from a year earlier. Discover B2B Marketing That Performs Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

$SLGNMedAI 8/10

Silgan (SLGN) Q2 2026 Earnings Call Transcript

Silgan (SLGN) held its Q2 2026 earnings call, reporting net sales of about $1.6 billion, up 7% year over year, and adjusted EPS of $0.98. Adjusted EPS was below the prior year due to lower adjusted EBIT. The company confirmed 2026 adjusted EPS guidance of $3.73 to $3.93 and gave Q3 2026 adjusted EPS guidance of $1.21 to $1.31.

$SLGNMed

SILGAN HOLDINGS INC (SLGN): Results of Operations and Financial Condition

SILGAN HOLDINGS INC (SLGN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 a991_63026.htm EX-99.1 Document Silgan Holdings Inc. Exhibit 99.1 SILGAN ANNOUNCES SECOND QUARTER 2026 RESULTS H ighlights • Achieved high single digit volume growth in dispensing products for fragrance markets • Delivered high single digit volume growth in metal contai

$JANMedAI 8/10

JAN Q2 Earnings Call Highlights

Janus Living (NYSE:JAN) reported sequential same-store NOI margin down 40 bps, citing seasonality. Occupancy rose for independent living but fell for skilled nursing. The company acquired two communities for $105M, sold one for $23M, and completed $1B more acquisitions post-quarter. It raised 2026 FFO guidance to $0.95-$0.98 and same-store adjusted NOI growth to 13%-17%.